We are aware of current issues with the ONS login. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
BTK Inhibitor Effective for Relapsed Hairy Cell Leukemia
Elisa Becze, BA, ELS, Editor
Voice
Description
Ibrutinib produces durable disease control for patients with high-risk hairy cell leukemia, a rare cancer, who have relapsed and for whom standard purine analogues are not a feasible therapeutic option, according to study results published in Blood.